The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMycelx Di Regulatory News (MYX)

Share Price Information for Mycelx Di (MYX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 65.00
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 2.00 (3.125%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 65.00
MYX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

21 May 2015 15:01

RNS Number : 9589N
MyCelx Technologies Corporation
21 May 2015
 



MyCelx Technologies Corporation

("MyCelx" or the "Company") (AIM: MYX)

 

21 May 2015

 

Grant of Share Option to Director

 

The Company announces that it has been notified on 20 May 2015 by Mark Clark, Chief Financial Officer and a director of the Company, that he was granted an option on 20 May 2015 under the MyCelx Omnibus Performance Incentive Plan ("Plan") over the Company's common shares of US$0.025 each ("Common Shares"). The grant to Mr. Clark was as follows:

 

Name of Director

Number of share options granted

Exercise price

Total number of share options held following this notification

Total number of share options as % of current issued share capital

Mark Clark

20,000

US$2.15 *

81,667

0.44%

 

In addition, following this transaction, Mr. Clark continues to be interested in 47,553 Common Shares, representing 0.26 per cent of the present issued capital of the Company.

 

Grant of Share Option to Chief Business Development Officer

 

The Company further announces that it has been notified on 20 May 2015 by Connie Mixon, Chief Executive Officer and a director of the Company, that her husband Mark Mixon, Chief Business Development Officer, was granted an option on 20 May 2015 under the Plan over 76,000 Common Shares. The grant to Mr. Mixon was as follows:

 

Name

Number of share options granted

Exercise price

Total number of share options held following this notification

Total number of share options as % of current issued share capital

Mark Mixon

76,000

US$2.15 *

200,204

1.07%

 

In addition, following this transaction, Mr. Mixon continues to be interested in 10,000 Common Shares, representing 0.05 per cent of the present issued capital of the Company, which he holds as custodian for his son.

 

Following this transaction, Ms. Mixon is interested in an aggregate (including the interests of Mr. Mixon) of 991,210 Common Shares, representing 5.32 per cent of the present issued capital of the Company, and in options over an aggregate (including the interests of Mr. Mixon) of 363,221 Common Shares, representing 1.95 per cent of the present issued capital of the Company.

 

The aggregate number of Common Shares held by Ms. Mixon also includes (a) 150,000 shares held by limited liability companies controlled by Ms. Mixon; and (b) 202,646 shares held by or on behalf of Ms. Mixon's children.

 

The above grants formed part of wider grants of 319,000 options to a total of fifteen employees across the Company, on the same date, representing 1.71% of the current issued share capital.

 

The share options granted on 20 May 2015 will vest as to one third on each of the first, second and third anniversaries of the date of grant, and must be exercised prior to the tenth anniversary of the date of grant, subject to the restrictions on dealing under the Company's share dealing code.

 

*Based on the mid-market closing price of the Company's Common Shares at 19 May 2015, and the closing US/£ exchange rate at that date.

 

 

For further information please contact:

 

MyCelx Technologies Corporation

Connie Mixon, CEO

Mark Clark, CFO

Tel: +1 888 306 6843

 

Numis Securities Limited

Corporate Finance

John Prior

Paul Gillam

 

Corporate Broking

James Black

Ben Stoop

Tel: +44 20 7260 1000

 

Bell Pottinger

Nick Lambert

Henry Lerwill

Tel: +44 20 3772 2500

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSLLFEVETILFIE
Date   Source Headline
15th Mar 20197:00 amRNSHolding(s) in Company
13th Mar 20197:00 amRNSIssue of Equity
28th Feb 20194:54 pmRNSResults of Fundraising
28th Feb 20197:00 amRNSProposed $1.8 million Placing
13th Feb 201910:22 amRNSTrading Update
21st Dec 20187:00 amRNSHolding(s) in Company
11th Dec 20187:15 amRNSDirectorate Changes
7th Dec 20187:00 amRNSBlock Admission Interim Update
29th Nov 20187:00 amRNSNew Project Award and Trading Update
8th Oct 20187:00 amRNSNew Project Award and Trading Update
12th Sep 20187:00 amRNSHalf Year Results Statement
27th Jul 20187:00 amRNSContract Extension in Saudi Arabia
11th Jul 20181:16 pmRNSResult of Annual Meeting
7th Jun 20184:23 pmRNSBlock listing Interim Review
7th Jun 20183:42 pmRNSAnnual Financial Report
15th May 20187:00 amRNSFinal Results for the year ending 31 December 2017
19th Apr 20187:00 amRNSNew Purchase Order Award and Equipment Sale
13th Apr 201810:18 amRNSIssue of Equity
10th Apr 20187:00 amRNSPurchase Order Award & General Manager Appointment
28th Mar 201812:48 pmRNSHolding(s) in Company
16th Feb 20187:00 amRNSIssue of Equity
6th Feb 20187:00 amRNSExtension of Contract and New Project
17th Jan 20187:00 amRNSTrading Update
7th Dec 20179:46 amRNSBlock listing Interim Review
3rd Nov 201712:39 pmRNSIssue of Equity
26th Oct 20177:30 amRNSHolding(s) in Company
9th Oct 20177:00 amRNSIssue of Equity
27th Sep 20172:44 pmRNSApplication for Block Admission
26th Sep 20175:31 pmRNSClosure of Restricted Stock Line
21st Sep 20177:00 amRNSConsolidation of Stock Lines
13th Sep 20177:00 amRNSHalf Year Results Statement
12th Jul 201712:30 pmRNSResult of Annual Meeting
7th Jul 20177:00 amRNSHalf Year Trading Update
9th Jun 201710:00 amRNSMailing of Annual Financial Report & GM Notice
7th Jun 201710:30 amRNSBlock listing Interim Review
30th May 20171:19 pmRNSDirector/PDMR Shareholding
26th May 20177:00 amRNSContract win with new SABIC affiliate customer
11th May 20177:00 amRNSFinal Results for the year ending 31 December 2016
8th May 20177:00 amRNSContract Award & Notification of Full Year Results
30th Jan 20177:00 amRNSTrading Update
7th Dec 20162:34 pmRNSBlock listing Interim Review
4th Oct 20167:00 amRNSAppointment of Nominated Adviser & Broker
14th Sep 20167:00 amRNSHalf Year Results Statement
13th Jul 20164:21 pmRNSResult of AGM
11th Jul 20167:00 amRNSHalf Year Trading Update
30th Jun 20167:00 amRNSHolding(s) in Company
24th Jun 20167:00 amRNSMyCelx and Schlumberger Sign Upstream Agreement
9th Jun 20167:00 amRNSMailing of 2015 Annual Report and Notice of AGM
7th Jun 20163:32 pmRNSBlock listing Interim Review
17th May 20167:00 amRNSFinal Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.